Skip to main content
NewslettersWatchlist

Staar Surgical Company(STAA-Q)
NASDAQ

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low45.86
Day High46.99
Open:46.61
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.
Select a category then submit the form to load news
Barchart
Stocks Slide in Today's Afternoon Trading Session
Barchart
Stocks Push Higher on Strength in Chip Stocks and Lower Bond Yields
PR Newswire
Jimmy O. Yang Partners with STAAR Surgical to Shine a Light on Their Vision Correction Lens, EVO ICL
PR Newswire
Dolby Laboratories Set to Join S&P MidCap 400; Staar Surgical to Join S&P SmallCap 600
Motley Fool
Why STAAR Surgical Stock Dropped Today
Motley Fool
10 Best Stocks to Buy Now, Stock Market News, and Investing Q&A
Motley Fool
2 Stocks With Unstoppable Growth Potential for the Next Decade
Business Wire
EVO ICL Sponsors Jonas Brothers’ The Tour
Business Wire
STAAR Surgical Reports First Quarter 2023 Results
Business Wire
STAAR Surgical to Report First Quarter Results on May 3, 2023
Business Wire
STAAR Surgical Names Warren Foust Chief Operating Officer; Magda Michna, Ph.D., Chief Clinical, Regulatory and Medical Affairs Officer
Business Wire
STAAR Surgical Reports Fourth Quarter and Fiscal Year 2022 Results
Business Wire
STAAR Surgical to Report Fourth Quarter and Fiscal Year Results on February 21, 2023
Business Wire
Actress and Beauty Entrepreneur Peyton List Sets Her Sights on 2023 with Upgraded Vision from Life-Changing EVO ICL Lenses
Business Wire
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
Motley Fool
Why Shares of STAAR Surgical Jumped 23.7% This Week
Business Wire
STAAR Surgical CEO Caren Mason to Retire; Tom Frinzi Appointed New CEO
Business Wire
STAAR Surgical Opens EVO Experience Center in United States
Business Wire
STAAR Surgical Reports Third Quarter Net Sales of $76 Million Up 30% Y/Y
Business Wire
STAAR Surgical to Report Third Quarter Results on November 2, 2022
Business Wire
Professional Basketball Player Max Strus Kicks Off New Season With Upgraded Vision From Life-Changing EVO ICL Lenses
Business Wire
STAAR Surgical Patient Awareness Campaign Launched In New York
Motley Fool
2 Ravenously Growing Stocks to Buy and Hold No Matter What
Motley Fool
Why STAAR Surgical Stock Is Triumphant Today
Business Wire
STAAR Surgical and Joe Jonas Team Up to Introduce New Life-Changing EVO ICL to Millions of Americans Suffering from Distance Vision Problems
Business Wire
STAAR Surgical Reports Record Second Quarter Net Sales of $81.1 Million Up 30% Y/Y
Motley Fool
3 Winning Evergreen Stocks to Buy and Hold for the Next 25 Years
Business Wire
STAAR Surgical to Report Second Quarter Results on August 10, 2022
Motley Fool
Should You Buy Stocks When the Market Crashes?
Business Wire
STAAR Surgical Celebrates Two Million Lens Milestone for Implantable Collamer® Lens (ICL)
Business Wire
STAAR Surgical Reports Record First Quarter Net Sales of $63.2 Million Up 25% Y/Y
Motley Fool
After Falling More Than 56% in a Year, Is STAAR Surgical Doomed?

Profile

Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2024.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2024 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.